KARLA GIESE: Open Payments
NPI 1780676262 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 15 payments from 7 companies in 2025. Trend: 2023 $586 · 2024 $2,985 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $192 |
| Dexcom, Inc. | 5 | $183 |
| Medtronic, Inc. | 2 | $106 |
| Tandem Diabetes Care, Inc. | 1 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $76 |
| Corcept Therapeutics | 1 | $33 |
| GlaxoSmithKline, LLC. | 2 | $29 |
Products named: Dexcom G6 Transmitter, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Kerendia, Korlym, SHINGRIX.
Industry payments across MI — which companies pay providers there.
